186 related articles for article (PubMed ID: 22782575)
1. ADAMTS13 exerts a thrombolytic effect in microcirculation.
Crescente M; Thomas GM; Demers M; Voorhees JR; Wong SL; Ho-Tin-Noé B; Wagner DD
Thromb Haemost; 2012 Sep; 108(3):527-32. PubMed ID: 22782575
[TBL] [Abstract][Full Text] [Related]
2. The mouse dorsal skinfold chamber as a model for the study of thrombolysis by intravital microscopy.
Boulaftali Y; Lamrani L; Rouzaud MC; Loyau S; Jandrot-Perrus M; Bouton MC; Ho-Tin-Noé B
Thromb Haemost; 2012 May; 107(5):962-71. PubMed ID: 22552380
[TBL] [Abstract][Full Text] [Related]
3. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
4. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
[TBL] [Abstract][Full Text] [Related]
5. Potent Thrombolytic Effect of
Martinez de Lizarrondo S; Gakuba C; Herbig BA; Repessé Y; Ali C; Denis CV; Lenting PJ; Touzé E; Diamond SL; Vivien D; Gauberti M
Circulation; 2017 Aug; 136(7):646-660. PubMed ID: 28487393
[TBL] [Abstract][Full Text] [Related]
6. Comparison of enoxaparin, hirulog, and heparin as adjunctive antithrombotic therapy during thrombolysis with rtPA in the stenosed canine coronary artery.
Leadley RJ; Kasiewski CJ; Bostwick JS; Bentley R; McVey MJ; White FJ; Perrone MH; Dunwiddie CT
Thromb Haemost; 1997 Oct; 78(4):1278-85. PubMed ID: 9364998
[TBL] [Abstract][Full Text] [Related]
7. ADAMTS13-mediated thrombolysis of t-PA-resistant occlusions in ischemic stroke in mice.
Denorme F; Langhauser F; Desender L; Vandenbulcke A; Rottensteiner H; Plaimauer B; François O; Andersson T; Deckmyn H; Scheiflinger F; Kleinschnitz C; Vanhoorelbeke K; De Meyer SF
Blood; 2016 May; 127(19):2337-45. PubMed ID: 26929275
[TBL] [Abstract][Full Text] [Related]
8. A novel hollow and perforated flexible wire allows the safe and effective local application of thrombolytic therapy in a mouse model of deep vein thrombosis.
Witsch T; Mauler M; Herr N; Stallmann D; Bode C; Hehrlein C; Duerschmied D
J Thromb Thrombolysis; 2014 May; 37(4):450-4. PubMed ID: 24163054
[TBL] [Abstract][Full Text] [Related]
9. Murine model of ferric chloride-induced vena cava thrombosis: evidence for effect of potato carboxypeptidase inhibitor.
Wang X; Smith PL; Hsu MY; Ogletree ML; Schumacher WA
J Thromb Haemost; 2006 Feb; 4(2):403-10. PubMed ID: 16420573
[TBL] [Abstract][Full Text] [Related]
10. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.
Zhao BQ; Chauhan AK; Canault M; Patten IS; Yang JJ; Dockal M; Scheiflinger F; Wagner DD
Blood; 2009 Oct; 114(15):3329-34. PubMed ID: 19687510
[TBL] [Abstract][Full Text] [Related]
11. Essential domains of a disintegrin and metalloprotease with thrombospondin type 1 repeats-13 metalloprotease required for modulation of arterial thrombosis.
Xiao J; Jin SY; Xue J; Sorvillo N; Voorberg J; Zheng XL
Arterioscler Thromb Vasc Biol; 2011 Oct; 31(10):2261-9. PubMed ID: 21799176
[TBL] [Abstract][Full Text] [Related]
12. VWF-targeted thrombolysis to overcome rh-tPA resistance in experimental murine ischemic stroke models.
van Moorsel MVA; de Maat S; Vercruysse K; van Leeuwen EM; Jacqmarcq C; Bonnard T; Vivien D; van der Worp HB; Dijkhuizen RM; Maas C
Blood; 2022 Dec; 140(26):2844-2848. PubMed ID: 35960811
[TBL] [Abstract][Full Text] [Related]
13. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic Modeling of Thrombolysis.
Loyau S; Ho-Tin-Noé B; Bourrienne MC; Boulaftali Y; Jandrot-Perrus M
Arterioscler Thromb Vasc Biol; 2018 Nov; 38(11):2626-2637. PubMed ID: 30354249
[TBL] [Abstract][Full Text] [Related]
15. Systemic antithrombotic effects of ADAMTS13.
Chauhan AK; Motto DG; Lamb CB; Bergmeier W; Dockal M; Plaimauer B; Scheiflinger F; Ginsburg D; Wagner DD
J Exp Med; 2006 Mar; 203(3):767-76. PubMed ID: 16533881
[TBL] [Abstract][Full Text] [Related]
16. Effective use of BCH-2763, a new potent injectable direct thrombin inhibitor, in combination with tissue plasminogen activator (tPA) in a rat arterial thrombolysis model.
Deschênes I; Finkle CD; Winocour PD
Thromb Haemost; 1998 Jul; 80(1):186-91. PubMed ID: 9684808
[TBL] [Abstract][Full Text] [Related]
17. Comparison of retavase and urokinase for management of spontaneous subclavian vein thrombosis.
Gelabert HA; Jimenez JC; Rigberg DA
Ann Vasc Surg; 2007 Mar; 21(2):149-54. PubMed ID: 17349354
[TBL] [Abstract][Full Text] [Related]
18. Releasing the Brakes on the Fibrinolytic System in Pulmonary Emboli: Unique Effects of Plasminogen Activation and α2-Antiplasmin Inactivation.
Singh S; Houng A; Reed GL
Circulation; 2017 Mar; 135(11):1011-1020. PubMed ID: 28028005
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effects of a novel recombinant hirudin, CX-397, in vivo and in vitro: comparison with recombinant hirudin variant-1, heparin, and argatroban.
Komatsu Y; Inoue Y; Goto Y; Fukazawa T; Hayashi H
Thromb Haemost; 1999 Feb; 81(2):250-5. PubMed ID: 10064001
[TBL] [Abstract][Full Text] [Related]
20. Plasma Peptidylarginine Deiminase IV Promotes VWF-Platelet String Formation and Accelerates Thrombosis After Vessel Injury.
Sorvillo N; Mizurini DM; Coxon C; Martinod K; Tilvawala R; Cherpokova D; Salinger AJ; Seward RJ; Staudinger C; Weerapana E; Shapiro NI; Costello CE; Thompson PR; Wagner DD
Circ Res; 2019 Aug; 125(5):507-519. PubMed ID: 31248335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
